{"id": "chatcmpl-8JYQwkqS6JcDWbjVV3HHm39OIRvco", "object": "chat.completion", "created": 1699671286, "model": "gpt-4-0613", "choices": [{"index": 0, "message": {"role": "assistant", "content": "1. Alirocumab undergoes target\u2010mediated clearance.\n2. The target for alirocumab's clearance is proprotein convertase subtilisin/kexin type 9 (PCSK9).\n3. Alirocumab binds to PCSK9 during its clearance process."}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 60, "completion_tokens": 60, "total_tokens": 120}, "temperature": 0, "max_tokens": 512, "top_p": 1, "frequency_penalty": 0, "presence_penalty": 0, "messages": [{"role": "system", "content": "Statement: Alirocumab undergoes target\u2010mediated clearance via binding of proprotein convertase subtilisin/kexin type 9 (PCSK9).\n\nList all the facts we explicitly know from the statement. Make each fact as atomic as possible."}]}